Buys
Open market- Shares
- Avg price
- Total value
Eric M. Dube - CHIEF EXECUTIVE OFFICER, Director at Travere Therapeutics, Inc.
Issuer-level insider activity
- Role
- CHIEF EXECUTIVE OFFICER, Director
- Issuer ticker
- TVTX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Eric M. Dube in Travere Therapeutics, Inc.
Sells
Open market- Shares
- -486,587
- Avg price
- $32.79
- Total value
- -$15,954,337
Net
Past year- Shares
- -486,587
- Share %
- -100%
- Total value
- -$15,954,337
Reported holdings for Eric M. Dube in Travere Therapeutics, Inc.
Form 4 holding
CHIEF EXECUTIVE OFFICER, Director
Travere Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 432,886
- Estimated value
- $19,025,339
- Report date
- 06 May 2026
- Price
- $43.95
- Ownership
- Direct
Form 4 holding
CHIEF EXECUTIVE OFFICER, Director
Travere Therapeutics, Inc.
- Security class
- Performance-based restricted stock units
- Shares / value
- 22,500
- Estimated value
- Report date
- 04 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
CHIEF EXECUTIVE OFFICER, Director
Travere Therapeutics, Inc.
- Security class
- Employee stock option (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 01 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Eric M. Dube in Travere Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.